Ignite Creation Date:
2025-12-24 @ 6:31 PM
Ignite Modification Date:
2026-04-16 @ 6:15 PM
Study NCT ID:
NCT05316857
Status:
COMPLETED
Last Update Posted:
2022-07-06
First Post:
2022-03-25
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
DDI Study of Orelabrutinib
Sponsor:
Beijing InnoCare Pharma Tech Co., Ltd.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
ICP-CL-00117
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None